CNTA Stock Analysis: Buy, Sell, or Hold?
CNTA - Centessa Pharmaceuticals plc American Depositary Shares
$40.33
0.15 (0.36%)
▲
5d:
+1.42%
30d:
+1.29%
90d:
+55.45%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When CNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CNTA is currently trading at $40.33, which is considered extended relative to its 30-day fair value range of $39.66 to $39.95.
Technical Outlook: Technically, CNTA is in a strong uptrend. The price is currently testing key support at $39.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNTA is in a strong uptrend. The price is currently testing key support at $39.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$39.66 -
$39.95
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($44.17)
Trading Range Analysis
30-Day Trading Range
$39.66 -
$39.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$39.58
Resistance Level
$40.14
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.46
Wall Street Target
$44.17
(+9.9%)
Share & Embed Analysis
Last updated: June 23, 2026 12:02 PM ET
Data refreshes hourly during market hours. Next update: 1:02 PM
Data refreshes hourly during market hours. Next update: 1:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Karen M Anderson
SELL
41076 shares
2026-03-26
Karen M Anderson
SELL
10043 shares
2026-03-17
Karen M Anderson
SELL
64768 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
